In MS samples, we demonstrate a highly significant increase in nonclassical monocytes ( CD 14+ CD 16++), with a concomitant significant reduction in classical monocytes ( CD 14++ CD 16−) compared with healthy controls.
← all excerpts
Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis.
1
—
—